From: Combination therapy design for maximizing sensitivity and minimizing toxicity
Breast
Lymphoma
BT474
A3KAW
COLO824
A4FUK
DU4475
BC1
EVSAT
CTB1
HCC1187
DOHH2
HCC2157
HT
HCC2218
KARPAS422
MFM223
MC116
MRKnu1
RL
OCUBM
TUR